4//SEC Filing
Patel Sushil 4
Accession 0001610717-24-000516
CIK 0001628171other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:05 PM ET
Size
8.6 KB
Accession
0001610717-24-000516
Insider Transaction Report
Form 4
Patel Sushil
Director
Transactions
- Exercise/Conversion
Common Stock
2024-10-31$24.84/sh+5,000$124,200→ 24,948 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-31−5,000→ 13,400 totalExercise: $24.84From: 2024-06-08Exp: 2033-06-07→ Common Stock (5,000 underlying) - Sale
Common Stock
2024-10-31$54.14/sh−5,000$270,715→ 19,948 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023.
- [F2]Includes 7,748 restricted stock units.
- [F3]The transaction was executed in multiple trades in prices ranging from $54.00 to $54.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001860609
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 4:05 PM ET
- Size
- 8.6 KB